Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I–II and operable stage III Taiwanese breast cancer patients-Reference-Cited by-同舟云学术

Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I–II and operable stage III Taiwanese breast cancer patients

Published:2008-12 Issue:6 Volume:17 Page:646-653
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Kuo Sung-Hsin,Lien Huang-Chun,You San-Lin,Lu Yen-Shen,Lin Ching-Hung,Chen T.-Zui,Huang Chiun-Sheng

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference36 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials;Lancet,2005

2. Adjuvant systemic therapy and survival after breast cancer;Olivotto;N Engl J Med,1994

3. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening;Quinn;BMJ,1995

4. Prognostic and predictive factors in early-stage breast cancer;Cianfocca;Oncologist,2004

5. Trials I through VII. Risk factors for locoregional recurrence among breast cancer patients: results from international breast cancer group trials I through VII;Wallgren;J Clin Oncol,2003

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Effects of a Telemonitoring Platform in the Development of Chemotherapy-Associated Toxicity: A Randomized Trial Protocol;Diagnostics;2024-03-14

2. Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational Study;Cancers;2023-12-29

3. Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer;Breast Cancer Research and Treatment;2023-12-09

4. MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer;Cellular Oncology;2023-05-11

5. The Effect of Probiotic and Synbiotic Consumption on the Most Prevalent Chemotherapy-related Complications: A Systematic Review of Current Literature;Current Medicinal Chemistry;2022-10